Delivery Order 36F79718D0586-36C24524N0293
Award Date
1/25/24
Potential Completion Date
1/30/24
Potential Value
$14K
Federal Agency
Veterans Integrated Service Network 5
Ultimate Awardee
Takeda Pharmaceutical Company LIMITED
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Earth City, MO 63045, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $13,956.72 firm-fixed-price delivery order contract to Takeda Pharmaceuticals America, Inc. for the supply of ICLUSIG 15 MG, a specialty oncology medication. This order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and supports the VA's procurement of critical drugs for its nationwide network of medical facilities. The contract has an ultimate completion date of November 11,...
The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceutical Company LIMITED is the parent company of the prime contractor. The contract was awarded against Takeda's Pharmaceuticals and Drugs GSA Schedule contract and will be performed in Earth City, Missouri over a four-day period from September 26-29, 2023. As the contract was awarded on a firm...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to supply ICLUSIG 15 MG tablets to the VA Veterans Integrated Service Network 5 facility in Earth City, Missouri, with performance from June 27 through 30, 2023. As the parent company, Takeda Pharmaceutical Company LIMITED backs Takeda Pharmaceuticals...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s GSA Schedule contract for pharmaceuticals and drugs. The order is for ICLUSIG 15 MG to be delivered to the VA medical center in Earth City, Missouri by December 12, 2023. Takeda Pharmaceutical Company LIMITED is the parent company of Takeda Pharmaceuticals America, Inc., the prime contractor performing under the firm-fixed price contract. The funding...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, for the supply of ICLUSIG 30MG TABS. This contract, valued at $173,884.68, is part of Takeda's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and utilizes firm-fixed pricing. The contract has a completion date of May 9,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $27,913.44 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule to Takeda Pharmaceuticals America, Inc. for EMERGENT ICLUSIG. Performance will take place in Earth City, Missouri, with a completion date of February 15, 2024. Takeda Pharmaceuticals America, Inc. is a foreign owned, for-profit manufacturer of goods, and is a subsidiary of...
The Department of Veterans Affairs (VA) awarded a $13,956.72 firm-fixed-price delivery order to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer, to provide ICLUSIG 15 MG, a specialty oncology medication, through the VA's Pharmaceuticals and Drugs Multiple Award Schedule contract. This delivery order is part of a larger $13 million single-award blanket purchase agreement held by Takeda with the VA National Acquisition Center to supply ICLUSIG products across the...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. The order is for ICLUSIG 15 MG to be delivered to the Veterans Integrated Service Network 5 facility in Earth City, Missouri, with performance taking place July 24-26, 2023. As the parent company, Takeda Pharmaceutical Company LIMITED backs Takeda Pharmaceuticals America, Inc. in...
Takeda Pharmaceuticals America, Inc. was awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, valued at $13,956.72, is for the pharmaceutical product ICLUSIG 15 MG and has a period of performance concluding on January 4, 2024. As no set-aside designation was used, the order was open to scheduling holders without...
This federal contract award is for the delivery of ICLUSIG 45MG TABLET and ICLUSIG 15MG TABLET pharmaceuticals to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $197,695.41 contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract was awarded as...